Abstract:Background. Most strategies for antirejection and tolerance induction in clinical transplantation have focused on modifying adaptive immunity, it is unclear whether pharmacological suppressing the innate immune systemcan promote transplant tolerance. Methods. We inhibited innate immunity by using our self-generated inhibitor of myeloid differentiation factor 88 (MyD88), TJ-M2010-5, and investigated its therapeutic effects and mechanisms in cardiac and skin transplant models. Results. TJ-M2010-5 directly and indirectly interacted with the Toll/IL-1R domain of MyD88, inhibiting MyD88 homodimerization. In vitro, TJ-M2010-5 inhibited maturation of dendritic cells, which suppressed nuclear translocation of NF-kappa B and Tcell activation. In vivo, short-term (10 days) monotherapy of TJ-M2010-5 resulted in long time survival of 50% of the cardiac allografts, and longer-term (14 days) combination treatment of TJ-M2010-5 with CD154 mAb resulted in survival of 29% of skin allografts, which outperformed far more than CsA did and stimulated the proliferation of CD4(+)CD25(+)FoxP3(+) Regulatory T cells in recipient mice. Conclusions. Pharmacological inhibition of MyD88 signaling by this novel inhibitor TJ-M2010-5 shows a powerful antirejection effect, which may have therapeutic potential in clinical transplantation. The inhibition of both innate and adaptive immunity may be necessary for tolerance induction in nonsolid organs.

Synthetic N-alkylated iminosugars as new potential immunosuppressive agents.

Synthesis of N-substituted iminosugar derivatives and their immunosuppressive activities

Synthetic Iminosugar Derivatives As New Potential Immunosuppressive Agents

Synthesis of N-Dialkylphosphoryl Iminosugar Derivatives and Their Immunosuppressive Activities

Synthesis of N‐Substituted Iminosugar Derivatives and Evaluation of Their Immunosuppressive Activities

N-Arylated-Lactam-Type Iminosugars As New Immunosuppressive Agents: Discovery, Optimization, and Biological Evaluation

Synthesis and Biological Evaluation of N-Arylated-Lactam-Type Iminosugars As Potential Immunosuppressive Agents

Design and Syntheses of Some Iminosugar Derivatives As Potential Immunosuppressants

ChemInform Abstract: Iminosugars As Immunomodulating Agents: Synthesis and Biological Activities of 1‐deoxynojirimycin and Related Compounds

Iminosugars As Immunomodulating Agents: Synthesis And Biological Activities Of 1-Deoxynojirimycin And Related Compounds

Iminosugar derivative WGN-26 suppresses acute allograft rejection via inhibiting the IFN-γ/p-STAT1/T-bet signaling pathway

An expeditious one-pot synthesis of 1,6-dideoxy-N-alkylated nojirimycin derivatives and their inhibitory effects on the secretion of IFN-γ and IL-4

Synthesis, molecular docking and biological evaluation of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents.

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Synthesis and Biological Activities of Amino Acids Functionalized Α-Galcer Analogues.

Synthesis, biological evaluation and molecular docking studies of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents

Design, Synthesis, and Immunosuppressive Activity of New Deoxybenzoin Derivatives

Design, Synthesis, and Biological Evaluation of Chalcone Oxime Derivatives As Potential Immunosuppressive Agents

Immunoregulatory Functions of Mulberry Branch Polysaccharides on Immunosuppressed Mice

Design, synthesis, biological evaluation and molecular modeling of novel 1,3,4-oxadiazole derivatives based on Vanillic acid as potential immunosuppressive agents.

(E)-1,3-diphenyl-1h-pyrazole Derivatives Containing O-benzyl Oxime Moiety As Potential Immunosuppressive Agents: Design, Synthesis, Molecular Docking and Biological Evaluation.